ECU
REGN icon

Eisler Capital (UK)’s Regeneron Pharmaceuticals REGN Stock Holding History

Eisler Capital (UK)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.85M Buy
8,418
+1,371
+19% +$1.53M 0.04% 290
2024
Q2 		$7.41M Buy
7,047
+1,853
+36% +$1.8M 0.05% 292
2024
Q1 		$5M Buy
5,194
+1,998
+63% +$1.9M 0.04% 295
2023
Q4 		$2.81M Buy
3,196
+2,510
+366% +$2.07M 0.02% 383
2023
Q3 		$565K Buy
+686
New +$539K ﹤0.01% 429

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Eisler Capital (UK)'s REGN Position: Q3 2024 in Review

Eisler Capital (UK) opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2024: 484 shares worth $509K. The stake represents ﹤0.01% of the portfolio and ranks #528 among its holdings. This is a return to the name: Eisler Capital (UK) previously reported a position in REGN as recently as Q1 2024.

Eisler Capital (UK) first reported a position in REGN in Q4 2021 and has held it in 4 quarters since. The position peaked at $2.06M in Q4 2021. 1,388 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • Eisler Capital (UK) held 484 shares of Regeneron Pharmaceuticals worth $509K as of Q3 2024.
  • Regeneron Pharmaceuticals was a new Eisler Capital (UK) position in Q3 2024.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #528 holding.
  • Eisler Capital (UK) first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • Eisler Capital (UK)'s Regeneron Pharmaceuticals position peaked at $2.06M in Q4 2021.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.